Our study is aimed to find biological markers that are clinically useful for predicting the severity of COVID-19 and determining immunothrombosis; we suggested that polymorphisms of cytokine genes IL2, IL6, and IL10 might play a role in the clinical manifestation and outcome of COVID-19 infection and might influence the production of the biological markers. Here, IL10 is linked to COVID-19.